The challenge to New Zealand’s vaccination rates isn’t hesitancy—it’s equal access
Lonza to up Moderna Covid jab output with Dutch production line
2 June 2021Most severe effects of PIMS-TS resolved at six months
2 June 2021The challenge to New Zealand’s vaccination rates isn’t hesitancy—it’s equal access
Reports of potentially higher rates of vaccine hesitancy among Māori and Pacific populations have seen the government target COVID-19 vaccine and information campaigns at those communities.
